- Conditions
- Breast Cancer, Postoperative Pain
- Interventions
- Liposomal bupivacaine, Bupivacaine with epinephrine, Morphine sulfate, Hydrocodone/acetaminophen, Diazepam
- Drug
- Lead sponsor
- Loma Linda University
- Other
- Eligibility
- 18 Years to 99 Years · Female only
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Loma Linda, California
Source: ClinicalTrials.gov public record
Updated Jan 11, 2021 · Synced May 22, 2026, 12:10 AM EDT